Short report: Idiopathic thrombocytopenic purpura and MMR vaccine
Open Access
- 1 March 2001
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 84 (3), 227-229
- https://doi.org/10.1136/adc.84.3.227
Abstract
A CAUSAL ASSOCIATION BETWEEN MEASLES mumps–rubella (MMR) vaccine and idiopathic thrombocytopenic purpura (ITP) was confirmed using immunisation/hospital admission record linkage. The absolute risk within six weeks of immunisation was 1 in 22 300 doses, with two of every three cases occurring in the six week post-immunisation period being caused by MMR. Children with ITP before MMR had no vaccine associated recurrences.Keywords
This publication has 9 references indexed in Scilit:
- Recurrent Thrombocytopenic Purpura After Repeated Measles-Mumps-Rubella VaccinationPEDIATRICS, 1996
- Relative Incidence Estimation from Case Series for Vaccine Safety EvaluationBiometrics, 1995
- A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccinesThe Lancet, 1995
- Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patientsActa Paediatrica, 1993
- Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.BMJ, 1987
- THROMBOCYTOPENIC PURPURA AFTER A COMBINED VACCINE AGAINST MORBILLI, PAROTITIS AND RUBELLAActa Paediatrica, 1983
- Thrombocytopenia in Childhood: An Evaluation of 433 PatientsScandinavian Journal of Haematology, 1976
- Effect of Live Measles Vaccine on the Platelet CountNew England Journal of Medicine, 1966